Obesity might not be a risk factor for female sexual dysfunction

Pinar Kadioglu, Demet Ozgil Yetkin, Oner Sanli, Ayse Serap Yalin, Kadir Onem, Ates Kadioglu

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate female sexual dysfunction (FSD) in obese women in comparison with age-matched control group, emphasising their hormonal and psychological status. PATIENTS, SUBJECTS AND METHODS Sixty-four sexually active obese premenauposal women were compared with a control group of 27 age-matched healthy volunteers with a normal body mass index (BMI). The obese group was evaluated in three categories according to BMI (kg/m2), as group 1 (30-34.9), group 2 (35-39.9) and group 3 (>40). All women were evaluated with Female Sexual Function Index (FSFI) questionnaire and Beck Depression Inventory (BDI). In addition, serum levels of follicle-stimulating hormone, luteinizing hormone, prolactin, dehydroepiandrosterone-SO4, free testosterone, 17α-hydroxyprogestrone, androstenedione, oestradiol, free thyroxine and thyrotropin were determined. RESULTS: The mean FSFI scores were not statistically significant between control and obese patients (P= 0.29). FSD was diagnosed in 50% (32/64) and 41% (11/27) of the patients in the obese and control groups, respectively (P= 0.34). There were no differences between total FSFI and FSFI domain scores among BMI categories. BDI scores were significantly higher in the obese groups than in healthy controls, and negatively correlated with total FSFI and all FSFI domain scores. Among hormonal analyses, only free testosterone levels were negatively correlated with total FSFI scores. CONCLUSION: This study showed that obesity has no significant relationship with FSD, but obese patients were found to be in a more depressive mood than age-matched normal counterparts.

Original languageEnglish (US)
Pages (from-to)1357-1361
Number of pages5
JournalBJU International
Volume106
Issue number9
DOIs
StatePublished - Nov 1 2010

Fingerprint

Obesity
Body Mass Index
Control Groups
Testosterone
Depression
Equipment and Supplies
Dehydroepiandrosterone
Androstenedione
Follicle Stimulating Hormone
Thyrotropin
Luteinizing Hormone
Thyroxine
Prolactin
Estradiol
Healthy Volunteers
Research Design
Psychology
Serum

Keywords

  • depression
  • hormones
  • obesity
  • sexual dysfunction

ASJC Scopus subject areas

  • Urology

Cite this

Kadioglu, P., Yetkin, D. O., Sanli, O., Yalin, A. S., Onem, K., & Kadioglu, A. (2010). Obesity might not be a risk factor for female sexual dysfunction. BJU International, 106(9), 1357-1361. https://doi.org/10.1111/j.1464-410X.2010.09348.x

Obesity might not be a risk factor for female sexual dysfunction. / Kadioglu, Pinar; Yetkin, Demet Ozgil; Sanli, Oner; Yalin, Ayse Serap; Onem, Kadir; Kadioglu, Ates.

In: BJU International, Vol. 106, No. 9, 01.11.2010, p. 1357-1361.

Research output: Contribution to journalArticle

Kadioglu, P, Yetkin, DO, Sanli, O, Yalin, AS, Onem, K & Kadioglu, A 2010, 'Obesity might not be a risk factor for female sexual dysfunction', BJU International, vol. 106, no. 9, pp. 1357-1361. https://doi.org/10.1111/j.1464-410X.2010.09348.x
Kadioglu, Pinar ; Yetkin, Demet Ozgil ; Sanli, Oner ; Yalin, Ayse Serap ; Onem, Kadir ; Kadioglu, Ates. / Obesity might not be a risk factor for female sexual dysfunction. In: BJU International. 2010 ; Vol. 106, No. 9. pp. 1357-1361.
@article{f7f79adaae764bd1b4f8fde632ede908,
title = "Obesity might not be a risk factor for female sexual dysfunction",
abstract = "OBJECTIVE: To evaluate female sexual dysfunction (FSD) in obese women in comparison with age-matched control group, emphasising their hormonal and psychological status. PATIENTS, SUBJECTS AND METHODS Sixty-four sexually active obese premenauposal women were compared with a control group of 27 age-matched healthy volunteers with a normal body mass index (BMI). The obese group was evaluated in three categories according to BMI (kg/m2), as group 1 (30-34.9), group 2 (35-39.9) and group 3 (>40). All women were evaluated with Female Sexual Function Index (FSFI) questionnaire and Beck Depression Inventory (BDI). In addition, serum levels of follicle-stimulating hormone, luteinizing hormone, prolactin, dehydroepiandrosterone-SO4, free testosterone, 17α-hydroxyprogestrone, androstenedione, oestradiol, free thyroxine and thyrotropin were determined. RESULTS: The mean FSFI scores were not statistically significant between control and obese patients (P= 0.29). FSD was diagnosed in 50{\%} (32/64) and 41{\%} (11/27) of the patients in the obese and control groups, respectively (P= 0.34). There were no differences between total FSFI and FSFI domain scores among BMI categories. BDI scores were significantly higher in the obese groups than in healthy controls, and negatively correlated with total FSFI and all FSFI domain scores. Among hormonal analyses, only free testosterone levels were negatively correlated with total FSFI scores. CONCLUSION: This study showed that obesity has no significant relationship with FSD, but obese patients were found to be in a more depressive mood than age-matched normal counterparts.",
keywords = "depression, hormones, obesity, sexual dysfunction",
author = "Pinar Kadioglu and Yetkin, {Demet Ozgil} and Oner Sanli and Yalin, {Ayse Serap} and Kadir Onem and Ates Kadioglu",
year = "2010",
month = "11",
day = "1",
doi = "10.1111/j.1464-410X.2010.09348.x",
language = "English (US)",
volume = "106",
pages = "1357--1361",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Obesity might not be a risk factor for female sexual dysfunction

AU - Kadioglu, Pinar

AU - Yetkin, Demet Ozgil

AU - Sanli, Oner

AU - Yalin, Ayse Serap

AU - Onem, Kadir

AU - Kadioglu, Ates

PY - 2010/11/1

Y1 - 2010/11/1

N2 - OBJECTIVE: To evaluate female sexual dysfunction (FSD) in obese women in comparison with age-matched control group, emphasising their hormonal and psychological status. PATIENTS, SUBJECTS AND METHODS Sixty-four sexually active obese premenauposal women were compared with a control group of 27 age-matched healthy volunteers with a normal body mass index (BMI). The obese group was evaluated in three categories according to BMI (kg/m2), as group 1 (30-34.9), group 2 (35-39.9) and group 3 (>40). All women were evaluated with Female Sexual Function Index (FSFI) questionnaire and Beck Depression Inventory (BDI). In addition, serum levels of follicle-stimulating hormone, luteinizing hormone, prolactin, dehydroepiandrosterone-SO4, free testosterone, 17α-hydroxyprogestrone, androstenedione, oestradiol, free thyroxine and thyrotropin were determined. RESULTS: The mean FSFI scores were not statistically significant between control and obese patients (P= 0.29). FSD was diagnosed in 50% (32/64) and 41% (11/27) of the patients in the obese and control groups, respectively (P= 0.34). There were no differences between total FSFI and FSFI domain scores among BMI categories. BDI scores were significantly higher in the obese groups than in healthy controls, and negatively correlated with total FSFI and all FSFI domain scores. Among hormonal analyses, only free testosterone levels were negatively correlated with total FSFI scores. CONCLUSION: This study showed that obesity has no significant relationship with FSD, but obese patients were found to be in a more depressive mood than age-matched normal counterparts.

AB - OBJECTIVE: To evaluate female sexual dysfunction (FSD) in obese women in comparison with age-matched control group, emphasising their hormonal and psychological status. PATIENTS, SUBJECTS AND METHODS Sixty-four sexually active obese premenauposal women were compared with a control group of 27 age-matched healthy volunteers with a normal body mass index (BMI). The obese group was evaluated in three categories according to BMI (kg/m2), as group 1 (30-34.9), group 2 (35-39.9) and group 3 (>40). All women were evaluated with Female Sexual Function Index (FSFI) questionnaire and Beck Depression Inventory (BDI). In addition, serum levels of follicle-stimulating hormone, luteinizing hormone, prolactin, dehydroepiandrosterone-SO4, free testosterone, 17α-hydroxyprogestrone, androstenedione, oestradiol, free thyroxine and thyrotropin were determined. RESULTS: The mean FSFI scores were not statistically significant between control and obese patients (P= 0.29). FSD was diagnosed in 50% (32/64) and 41% (11/27) of the patients in the obese and control groups, respectively (P= 0.34). There were no differences between total FSFI and FSFI domain scores among BMI categories. BDI scores were significantly higher in the obese groups than in healthy controls, and negatively correlated with total FSFI and all FSFI domain scores. Among hormonal analyses, only free testosterone levels were negatively correlated with total FSFI scores. CONCLUSION: This study showed that obesity has no significant relationship with FSD, but obese patients were found to be in a more depressive mood than age-matched normal counterparts.

KW - depression

KW - hormones

KW - obesity

KW - sexual dysfunction

UR - http://www.scopus.com/inward/record.url?scp=78349291927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349291927&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2010.09348.x

DO - 10.1111/j.1464-410X.2010.09348.x

M3 - Article

C2 - 20394615

AN - SCOPUS:78349291927

VL - 106

SP - 1357

EP - 1361

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 9

ER -